Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Buy
57
NYT Quote, Financials, Valuation and Earnings
Last price:
$53.41
Seasonality move
:
6.36%
Day range:
$52.43 - $53.12
52-week range:
$41.55 - $58.16
Dividend yield:
0.95%
P/E ratio:
31.31x
P/S ratio:
3.46x
P/B ratio:
4.68x
Volume:
932.8K
Avg. volume:
1.4M
1-year change:
15.07%
Market cap:
$8.7B
Revenue:
$2.4B
EPS (TTM):
$1.69
Analysts' Opinion
-
Consensus RatingNew York Times has received a consensus rating of Buy. The company's average rating is a Buy based on 5 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $58.00, New York Times has an estimated upside of 9.6% from its current price of $52.92.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $45.00 representing 100% downside risk from its current price of $52.92.
Fair Value
-
According to the consensus of 8 analysts, New York Times has 9.6% upside to fair value with a price target of $58.00 per share.
NYT vs. S&P 500
-
Over the past 5 trading days, New York Times has underperformed the S&P 500 by -6.43% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
New York Times does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
New York Times has grown year-over-year revenues for 16 quarters straight. In the most recent quarter New York Times reported revenues of $640.2M.
Earnings Growth
-
New York Times has grown year-over-year earnings for 5 quarters straight. In the most recent quarter New York Times reported earnings per share of $0.39.
Enterprise value:
8.2B
EV / Invested capital:
4.42x
Price / LTM sales:
3.46x
EV / EBIT:
22.20x
EV / Revenue:
3.23x
PEG ratio (5yr expected):
0.69x
EV / Free cash flow:
22.23x
Price / Operating cash flow:
23.84x
Enterprise value / EBITDA:
17.74x
Gross Profit (TTM):
$1.2B
Return On Assets:
10.51%
Net Income Margin (TTM):
11.04%
Return On Equity:
15.87%
Return On Invested Capital:
15.87%
Operating Margin:
12.71%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $2.2B | $2.4B | $2.5B | $598.3M | $640.2M | |
| Gross Profit | $1.1B | $1.2B | $1.2B | $287.2M | $308.3M | |
| Operating Income | $237.8M | $274.5M | $340.5M | $66.1M | $81.3M | |
| EBITDA | $320.9M | $352.7M | $461.3M | $93.9M | $108.2M | |
| Diluted EPS | $1.03 | $1.16 | $1.69 | $0.32 | $0.39 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $721M | $925.7M | $543.2M | $658.1M | $795M | |
| Total Assets | $2.1B | $2.5B | $2.5B | $2.5B | $2.8B | |
| Current Liabilities | $425.9M | $526.6M | $555.8M | $554M | $589.6M | |
| Total Liabilities | $882.3M | $999.9M | $973M | $891.3M | $910M | |
| Total Equity | $1.3B | $1.5B | $1.5B | $1.7B | $1.9B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $144.6M | $289.8M | $395.3M | $104.3M | $125.5M | |
| Cash From Investing | -$130.4M | -$91.6M | -$259.9M | -$92.3M | -$101.3M | |
| Cash From Financing | -$145.2M | -$152.9M | -$165.5M | -$21.7M | -$42.3M | |
| Free Cash Flow | $105.9M | $264.1M | $368.1M | $98.6M | $118.4M | |
NYT
Sector
Market Cap
$8.7B
$112.9M
Price % of 52-Week High
90.99%
65.22%
Dividend Yield
0.95%
0%
Shareholder Yield
1.53%
3.48%
1-Year Price Total Return
15.07%
-17.6%
Beta (5-Year)
0.998
0.704
Dividend yield:
0.95%
Annualized payout:
$0.42
Payout ratio:
28.43%
Growth streak:
5 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$54.09
200-day SMA
Buy
Level
$51.17
Bollinger Bands (100)
Sell
Level
53.35 - 55.63
Chaikin Money Flow
Buy
Level
226.6M
20-day SMA
Sell
Level
$54.60
Relative Strength Index (RSI14)
Sell
Level
40.34
ADX Line
Sell
Level
13.78
Williams %R
Buy
Level
-91.4485
50-day SMA
Sell
Level
$54.66
MACD (12, 26)
Sell
Level
-0.30
25-day Aroon Oscillator
Buy
Level
48
On Balance Volume
Neutral
Level
180.2M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (7.514)
Buy
CA Score
(Annual)
Level (1.0642)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (8)
Buy
Ohlson Score
Level (-1.7718)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as NYTimes and various smartphone applications. The company has two segments New York Times Group and The Athletic. The company generates the majority of its revenue from the NYTG segment. The NYTG and The Athletic segments derive revenue from subscriptions, Advertising, and others, where the major source of revenue for both segments is subscription.
Stock Forecast FAQ
In the current month, NYT has received 5 Buy ratings 3 Hold ratings, and 0 Sell ratings. The NYT average analyst price target in the past 3 months is $58.00.
-
Where Will New York Times Stock Be In 1 Year?
According to analysts, the consensus estimate is that New York Times share price will rise to $58.00 per share over the next 12 months.
-
What Do Analysts Say About New York Times?
Analysts are divided on their view about New York Times share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that New York Times is a Sell and believe this share price will drop from its current level to $45.00.
-
What Is New York Times's Price Target?
The price target for New York Times over the next 1-year time period is forecast to be $58.00 according to 8 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.
-
Is NYT A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for New York Times is a Buy. 5 of 8 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of NYT?
You can purchase shares of New York Times via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase New York Times shares.
-
What Is The New York Times Share Price Today?
New York Times was last trading at $53.41 per share. This represents the most recent stock quote for New York Times. Yesterday, New York Times closed at $52.92 per share.
-
How To Buy New York Times Stock Online?
In order to purchase New York Times stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
73
PSIX alert for Dec 24
Power Solutions International [PSIX] is up 27.42% over the past day.
Sell
40
MSTR alert for Dec 24
MicroStrategy [MSTR] is up 8.07% over the past day.
Sell
26
NUTX alert for Dec 24
Nutex Health [NUTX] is down 1.39% over the past day.
